Accuracy of Roche SARS-CoV-2 Rapid Antigen Test in Nasopharyngeal Swab: Clinical Impression Matters

K. Pyar, Khine Khine Su, K. Wunna, M. Thant, K. Myat, A. Aung, Zar Ni Htet Aung, N. L. Maung, A. Kyaw, Min Lynn Zaw Oo, Kyaw Zwa Tun, Kyaw Ko Ko Aung, K. Thu, Thein Soe Tun, Nyan Ye Oo, Chan Nyein Latt, Thida Tun, Si Thu Myint, A. P. Oo, Win Ko Ko Min, Kyaw Khine Win, He Yan, Thet Mg Oo, Win Myint Tin
{"title":"Accuracy of Roche SARS-CoV-2 Rapid Antigen Test in Nasopharyngeal Swab: Clinical Impression Matters","authors":"K. Pyar, Khine Khine Su, K. Wunna, M. Thant, K. Myat, A. Aung, Zar Ni Htet Aung, N. L. Maung, A. Kyaw, Min Lynn Zaw Oo, Kyaw Zwa Tun, Kyaw Ko Ko Aung, K. Thu, Thein Soe Tun, Nyan Ye Oo, Chan Nyein Latt, Thida Tun, Si Thu Myint, A. P. Oo, Win Ko Ko Min, Kyaw Khine Win, He Yan, Thet Mg Oo, Win Myint Tin","doi":"10.37871/jbres1334","DOIUrl":null,"url":null,"abstract":"Background: In COVID-19 pandemic, the diagnosis and treatment must be as early as possible to save the life of each patient. Moreover, screening of asymptomatic carriers, close contacts or healthy subjects must not be delay to prevent transmission to publics. For confirmation of diagnosis of SARS-CoV-2 infection, nasopharyngeal swab must be tested either by real-time Reverse Transcription Polymerase Chain Reaction (RT-PCR) tests or Rapid Antigen Test (RAT). RAT is faster, easier and cheaper; thus, it is suitable for health service in developing country. Objectives: The aim of this study was to assess the diagnostic accuracy of Roche SARS-CoV-2 Rapid Antigen Test (RAT) in diagnosing SARS-CoV-2 infection. Methods: Hospital based exploratory study was done in out-patient department and fever clinic, and molecular laboratory of No. (1) Defence Services General Hospital. Nasopharyngeal swabs were taken, and the Roche SARS- CoV-2 RAT was conducted in parallel with RT-PCR test (reference standard). Results: Among the 932 patients/subjects recruited, RT-PCR was positive in 468 individuals, corresponding to a prevalence of 50.2%. The RAT was positive in 363 patients (60.4%), false positive in 120 patients; it was negative in 569 individuals (39.6%), false negative in 225 patients. The overall sensitivity of the RAT was 51.9% (95% Confidence Interval [CI] 47.29-56.53) and, the specificity was 74.1% (95% CI 69.9-78.07); positive predictive value was 66.9% and negative predictive value was 60.5%. The sensitivity varied with Ct value; 78% in clinical samples with Ct values < 20, 57.5% in those with Ct values between 21 and 25, 41.8% in samples with Ct values between 26 and 30, and, 36.4% in samples with Ct value > 30. Conclusion: The accuracy of the SARS-CoV-2 Roche RAT in diagnosing SARS-CoV-2 infections was inferior to RT-PCR and manufacturer’s data. The sensitivity was with low Cycle threshold values < 20 which were inversely related to the viral load. RAT test should be used in association with clinical impression of physicians. In hospital setting especially in emergency department, the role of RAT should be reconsidered in those patients presenting with anosmia and some cases of dyspnoea, late symptoms in the course of disease, as the RAT results would be false negative. Other errors may arise if the operator for RAT has to handle more than recommended tests per hour especially in the peak of epidemics.","PeriodicalId":94067,"journal":{"name":"Journal of biomedical research & environmental sciences","volume":"C-23 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of biomedical research & environmental sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37871/jbres1334","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: In COVID-19 pandemic, the diagnosis and treatment must be as early as possible to save the life of each patient. Moreover, screening of asymptomatic carriers, close contacts or healthy subjects must not be delay to prevent transmission to publics. For confirmation of diagnosis of SARS-CoV-2 infection, nasopharyngeal swab must be tested either by real-time Reverse Transcription Polymerase Chain Reaction (RT-PCR) tests or Rapid Antigen Test (RAT). RAT is faster, easier and cheaper; thus, it is suitable for health service in developing country. Objectives: The aim of this study was to assess the diagnostic accuracy of Roche SARS-CoV-2 Rapid Antigen Test (RAT) in diagnosing SARS-CoV-2 infection. Methods: Hospital based exploratory study was done in out-patient department and fever clinic, and molecular laboratory of No. (1) Defence Services General Hospital. Nasopharyngeal swabs were taken, and the Roche SARS- CoV-2 RAT was conducted in parallel with RT-PCR test (reference standard). Results: Among the 932 patients/subjects recruited, RT-PCR was positive in 468 individuals, corresponding to a prevalence of 50.2%. The RAT was positive in 363 patients (60.4%), false positive in 120 patients; it was negative in 569 individuals (39.6%), false negative in 225 patients. The overall sensitivity of the RAT was 51.9% (95% Confidence Interval [CI] 47.29-56.53) and, the specificity was 74.1% (95% CI 69.9-78.07); positive predictive value was 66.9% and negative predictive value was 60.5%. The sensitivity varied with Ct value; 78% in clinical samples with Ct values < 20, 57.5% in those with Ct values between 21 and 25, 41.8% in samples with Ct values between 26 and 30, and, 36.4% in samples with Ct value > 30. Conclusion: The accuracy of the SARS-CoV-2 Roche RAT in diagnosing SARS-CoV-2 infections was inferior to RT-PCR and manufacturer’s data. The sensitivity was with low Cycle threshold values < 20 which were inversely related to the viral load. RAT test should be used in association with clinical impression of physicians. In hospital setting especially in emergency department, the role of RAT should be reconsidered in those patients presenting with anosmia and some cases of dyspnoea, late symptoms in the course of disease, as the RAT results would be false negative. Other errors may arise if the operator for RAT has to handle more than recommended tests per hour especially in the peak of epidemics.
罗氏SARS-CoV-2快速抗原检测在鼻咽拭子中的准确性:临床印象问题
背景:在COVID-19大流行中,必须尽早诊断和治疗,以挽救每一位患者的生命。对无症状感染者、密切接触者或健康人群的筛查不得拖延,防止向公众传播。为确诊SARS-CoV-2感染,必须采用实时逆转录聚合酶链反应(RT-PCR)或快速抗原检测(RAT)对鼻咽拭子进行检测。RAT更快、更容易、更便宜;因此,它适用于发展中国家的卫生服务。目的:评价罗氏SARS-CoV-2快速抗原试验(RAT)诊断SARS-CoV-2感染的准确性。方法:在医院门诊部、发热门诊、分子实验室开展以医院为基础的探索性研究。(1)国防服务总医院。取鼻咽拭子,与对照品RT-PCR平行进行Roche SARS- CoV-2 RAT检测。结果:在所招募的932名患者/受试者中,有468人RT-PCR阳性,患病率为50.2%。RAT阳性363例(60.4%),假阳性120例;阴性569例(39.6%),假阴性225例。RAT的总敏感性为51.9%(95%可信区间[CI] 47.29-56.53),特异性为74.1% (95% CI 699 -78.07);阳性预测值为66.9%,阴性预测值为60.5%。灵敏度随Ct值的变化而变化;Ct值< 20的临床样本占78%,21 ~ 25的临床样本占57.5%,26 ~ 30的临床样本占41.8%,> 30的临床样本占36.4%。结论:SARS-CoV-2 Roche大鼠诊断SARS-CoV-2感染的准确性低于RT-PCR和生产厂家数据。敏感性低周期阈值< 20,与病毒载量呈负相关。RAT试验应与医生的临床印象结合使用。在医院特别是急诊科,对于出现嗅觉缺失和部分呼吸困难的患者,应重新考虑RAT的作用,因为RAT结果可能是假阴性的。如果RAT操作员每小时必须处理超过建议的测试,特别是在流行病高峰期,可能会出现其他错误。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信